Search
forResearch 3 of 25
- Results of Open-Label non-Randomized Comparative Clinical Trial: “BromhexIne and Spironolactone for CoronаvirUs Infection requiring hospiTalization (BISCUIT)
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- An update of anti-viral treatment of COVID-19
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →